Seth Dahlberg to Radiopharmaceuticals
This is a "connection" page, showing publications Seth Dahlberg has written about Radiopharmaceuticals.
Connection Strength
0.611
-
Dahlberg ST. Assessment of myocardial perfusion with Tc-99m: image is everything. J Nucl Cardiol. 2009 Jul-Aug; 16(4):493-6.
Score: 0.302
-
Pretorius PH, Ramon AJ, King MA, Konik A, Dahlberg ST, Parker MW, Botkin NF, Johnson KL, Yang Y, Wernick MN. Retrospective fractional dose reduction in Tc-99m cardiac perfusion SPECT/CT patients: A human and model observer study. J Nucl Cardiol. 2021 04; 28(2):624-637.
Score: 0.151
-
Hansen CL, Goldstein RA, Berman DS, Churchwell KB, Cooke CD, Corbett JR, Cullom SJ, Dahlberg ST, Galt JR, Garg RK, Heller GV, Hyun MC, Johnson LL, Mann A, McCallister BD, Taillefer R, Ward RP, Mahmarian JJ. Myocardial perfusion and function single photon emission computed tomography. J Nucl Cardiol. 2006 Nov; 13(6):e97-120.
Score: 0.064
-
Feng B, Pretorius PH, Farncombe TH, Dahlberg ST, Narayanan MV, Wernick MN, Celler AM, Leppo JA, King MA. Simultaneous assessment of cardiac perfusion and function using 5-dimensional imaging with Tc-99m teboroxime. J Nucl Cardiol. 2006 May-Jun; 13(3):354-61.
Score: 0.061
-
Pretorius PH, Johnson KL, Dahlberg ST, King MA. Investigation of the physical effects of respiratory motion compensation in a large population of patients undergoing Tc-99m cardiac perfusion SPECT/CT stress imaging. J Nucl Cardiol. 2020 02; 27(1):80-95.
Score: 0.033